BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 11092756)

  • 1. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
    Trettel F; Rigamonti D; Hilditch-Maguire P; Wheeler VC; Sharp AH; Persichetti F; Cattaneo E; MacDonald ME
    Hum Mol Genet; 2000 Nov; 9(19):2799-809. PubMed ID: 11092756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles.
    Hilditch-Maguire P; Trettel F; Passani LA; Auerbach A; Persichetti F; MacDonald ME
    Hum Mol Genet; 2000 Nov; 9(19):2789-97. PubMed ID: 11092755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
    Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
    Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
    Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.
    Wheeler VC; Gutekunst CA; Vrbanac V; Lebel LA; Schilling G; Hersch S; Friedlander RM; Gusella JF; Vonsattel JP; Borchelt DR; MacDonald ME
    Hum Mol Genet; 2002 Mar; 11(6):633-40. PubMed ID: 11912178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
    Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R
    Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
    Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
    Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
    Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
    Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.
    Williams BB; Kwakye GF; Wegrzynowicz M; Li D; Aschner M; Erikson KM; Bowman AB
    Toxicol Sci; 2010 Sep; 117(1):169-79. PubMed ID: 20547568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.
    Li H; Li SH; Yu ZX; Shelbourne P; Li XJ
    J Neurosci; 2001 Nov; 21(21):8473-81. PubMed ID: 11606636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
    Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
    PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.
    Wheeler VC; White JK; Gutekunst CA; Vrbanac V; Weaver M; Li XJ; Li SH; Yi H; Vonsattel JP; Gusella JF; Hersch S; Auerbach W; Joyner AL; MacDonald ME
    Hum Mol Genet; 2000 Mar; 9(4):503-13. PubMed ID: 10699173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
    Dunah AW; Jeong H; Griffin A; Kim YM; Standaert DG; Hersch SM; Mouradian MM; Young AB; Tanese N; Krainc D
    Science; 2002 Jun; 296(5576):2238-43. PubMed ID: 11988536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.
    Wheeler VC; Lebel LA; Vrbanac V; Teed A; te Riele H; MacDonald ME
    Hum Mol Genet; 2003 Feb; 12(3):273-81. PubMed ID: 12554681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.